Kiniksa Pharmaceuticals LtdNASDAQ:KNSA
- LAST PRICE25.0000
- TODAY'S CHANGE (%)1.0400 (4.3406%)
- Bid / Lots25.0000/ 1
- Ask / Lots27.3500/ 1
- Open / Previous Close24.2400 / 23.9600
- Day Range
- 52 Week Range
- Volume425,143
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | KNSA |
|---|---|---|
| 09:32 ET | 1520 | 24.24 |
| 09:41 ET | 1250 | 24.1655 |
| 09:43 ET | 700 | 24.125 |
| 09:45 ET | 100 | 24.125 |
| 09:48 ET | 300 | 24.15 |
| 09:50 ET | 100 | 24.11 |
| 09:54 ET | 2500 | 24.07 |
| 09:56 ET | 100 | 24.09 |
| 09:57 ET | 200 | 24.11 |
| 09:59 ET | 800 | 24.09 |
| 10:01 ET | 300 | 24.04 |
| 10:03 ET | 1780 | 24.13 |
| 10:08 ET | 200 | 24.1883 |
| 10:12 ET | 100 | 24.14 |
| 10:15 ET | 100 | 24.05 |
| 10:17 ET | 100 | 24.04 |
| 10:19 ET | 100 | 24.08 |
| 10:21 ET | 314 | 24.115 |
| 10:24 ET | 400 | 24.16 |
| 10:26 ET | 100 | 24.11 |
| 10:28 ET | 500 | 24.11 |
| 10:32 ET | 400 | 24.095 |
| 10:35 ET | 100 | 24.11 |
| 10:37 ET | 300 | 24.15 |
| 10:39 ET | 1623 | 24.2675 |
| 10:42 ET | 378 | 24.23 |
| 10:44 ET | 200 | 24.2 |
| 10:48 ET | 500 | 24.24 |
| 10:50 ET | 100 | 24.24 |
| 10:51 ET | 1000 | 24.22 |
| 10:53 ET | 100 | 24.16 |
| 10:55 ET | 100 | 24.14 |
| 11:04 ET | 101 | 24.134 |
| 11:06 ET | 1200 | 24.145 |
| 11:08 ET | 357 | 24.168 |
| 11:09 ET | 100 | 24.18 |
| 11:11 ET | 400 | 24.19 |
| 11:13 ET | 500 | 24.17 |
| 11:15 ET | 200 | 24.17 |
| 11:18 ET | 506 | 24.19 |
| 11:22 ET | 500 | 24.16 |
| 11:24 ET | 100 | 24.22 |
| 11:26 ET | 600 | 24.17 |
| 11:27 ET | 500 | 24.17 |
| 11:29 ET | 1000 | 24.18 |
| 11:33 ET | 607 | 24.25 |
| 11:36 ET | 800 | 24.24 |
| 11:38 ET | 500 | 24.235 |
| 11:40 ET | 200 | 24.195 |
| 11:42 ET | 100 | 24.18 |
| 11:44 ET | 1100 | 24.2 |
| 11:45 ET | 100 | 24.17 |
| 11:47 ET | 100 | 24.165 |
| 11:49 ET | 300 | 24.22 |
| 11:51 ET | 300 | 24.17 |
| 12:00 ET | 3100 | 24.19 |
| 12:02 ET | 1100 | 24.17 |
| 12:03 ET | 600 | 24.17 |
| 12:05 ET | 326 | 24.1657 |
| 12:07 ET | 500 | 24.155 |
| 12:12 ET | 100 | 24.12 |
| 12:14 ET | 100 | 24.11 |
| 12:16 ET | 700 | 24.02 |
| 12:18 ET | 200 | 24.055 |
| 12:21 ET | 4780 | 24 |
| 12:23 ET | 810 | 24.03 |
| 12:25 ET | 100 | 24.09 |
| 12:30 ET | 300 | 24.125 |
| 12:32 ET | 100 | 24.14 |
| 12:34 ET | 200 | 24.1275 |
| 12:36 ET | 100 | 24.13 |
| 12:38 ET | 200 | 24.11 |
| 12:39 ET | 1533 | 24.12 |
| 12:43 ET | 1100 | 24.05 |
| 12:45 ET | 480 | 24.02 |
| 12:48 ET | 100 | 24.06 |
| 12:50 ET | 100 | 24.06 |
| 12:56 ET | 800 | 24.03 |
| 12:57 ET | 300 | 24.04 |
| 12:59 ET | 100 | 24.055 |
| 01:01 ET | 200 | 24.055 |
| 01:06 ET | 200 | 24.05 |
| 01:08 ET | 200 | 24.05 |
| 01:10 ET | 500 | 24.02 |
| 01:12 ET | 1163 | 24.055 |
| 01:14 ET | 800 | 24.07 |
| 01:15 ET | 100 | 24.07 |
| 01:26 ET | 700 | 24.18 |
| 01:30 ET | 200 | 24.175 |
| 01:32 ET | 500 | 24.19 |
| 01:33 ET | 44420 | 24.25 |
| 01:35 ET | 200 | 24.26 |
| 01:37 ET | 230 | 24.255 |
| 01:39 ET | 200 | 24.255 |
| 01:42 ET | 400 | 24.255 |
| 01:44 ET | 1940 | 24.33 |
| 01:46 ET | 52572 | 24.48 |
| 01:48 ET | 200 | 24.5 |
| 01:50 ET | 800 | 24.56 |
| 01:55 ET | 900 | 24.61 |
| 02:00 ET | 100 | 24.65 |
| 02:02 ET | 6979 | 24.77 |
| 02:04 ET | 2724 | 24.855 |
| 02:06 ET | 3144 | 24.87 |
| 02:08 ET | 600 | 24.9 |
| 02:09 ET | 300 | 24.9 |
| 02:11 ET | 2767 | 24.87 |
| 02:13 ET | 5555 | 24.8 |
| 02:15 ET | 200 | 24.755 |
| 02:20 ET | 1135 | 24.78 |
| 02:26 ET | 2030 | 24.735 |
| 02:27 ET | 1100 | 24.66 |
| 02:29 ET | 800 | 24.665 |
| 02:31 ET | 2680 | 24.65 |
| 02:33 ET | 1000 | 24.6 |
| 02:36 ET | 331 | 24.62 |
| 02:38 ET | 550 | 24.62 |
| 02:40 ET | 904 | 24.62 |
| 02:45 ET | 300 | 24.66 |
| 02:47 ET | 300 | 24.695 |
| 02:51 ET | 400 | 24.69 |
| 02:54 ET | 100 | 24.71 |
| 02:56 ET | 2848 | 24.695 |
| 02:58 ET | 100 | 24.72 |
| 03:02 ET | 2500 | 24.74 |
| 03:03 ET | 326 | 24.735 |
| 03:05 ET | 3700 | 24.7 |
| 03:12 ET | 200 | 24.73 |
| 03:14 ET | 3962 | 24.655 |
| 03:16 ET | 400 | 24.655 |
| 03:18 ET | 100 | 24.655 |
| 03:20 ET | 937 | 24.72 |
| 03:21 ET | 1000 | 24.72 |
| 03:23 ET | 1717 | 24.73 |
| 03:25 ET | 900 | 24.747 |
| 03:27 ET | 4309 | 24.725 |
| 03:30 ET | 4700 | 24.775 |
| 03:32 ET | 900 | 24.75 |
| 03:34 ET | 1640 | 24.755 |
| 03:36 ET | 400 | 24.77 |
| 03:38 ET | 100 | 24.78 |
| 03:43 ET | 5785 | 24.79 |
| 03:45 ET | 2522 | 24.68 |
| 03:50 ET | 1133 | 24.76 |
| 03:52 ET | 1300 | 24.77 |
| 03:54 ET | 2233 | 24.74 |
| 03:56 ET | 600 | 24.74 |
| 03:57 ET | 7102 | 24.89 |
| 03:59 ET | 66588 | 25 |
Sep 13, 2024
DJ Kiniksa Pharmaceuticals Initiated at Buy by Jefferies, from 9:15AM ET on Friday Sep 13, 2024 by Dow Jones
9:15AM ET on Friday Sep 13, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Kiniksa Pharmaceuticals Ltd | 1.8B | -139.8x | --- |
Zai Lab Ltd | 2.1B | -7.7x | --- |
CareDx Inc | 1.5B | -9.9x | --- |
Maravai LifeSciences Holdings Inc | 2.1B | -8.4x | --- |
MannKind Corp | 1.7B | 172.8x | --- |
BioCryst Pharmaceuticals Inc | 1.6B | -10.4x | --- |
Company Information
Kiniksa Pharmaceuticals, Ltd. is a biopharmaceutical company. The Company is focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its portfolio of immune-modulating assets, ARCALYST (rilonacept), KPL-404 and mavrilimumab, are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. The Company’s ARCALYST is interleukin-1alpha (IL-1α), and interleukin-1beta (IL-1β), cytokine trap for the treatment of recurrent pericarditis and reduction in risk of recurrence in adults and children. Its KPL-404 is an investigational monoclonal antibody inhibitor of CD40-CD154 interaction. The Company’s Mavrilimumab is an investigational monoclonal antibody inhibitor targeting granulocyte-macrophage colony stimulating factor receptor alpha (GM-CSFRα).
Contact Information
- Headquarters
- Clarendon House, 2 Church StreetHAMILTON, Bermuda HM11
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Sanjiv Patel
- Chief Financial Officer, Senior Vice President
- Mark Ragosa
- Chief Operating Officer, Senior Vice President
- Eben Tessari
- Senior Vice President, Chief Commercial Officer
- Ross Moat
- Senior Vice President, Chief Medical Officer
- John Paolini
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.8B |
|---|---|
Revenue (TTM) | $338.9M |
Shares Outstanding | 71.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.32 |
EPS | $-0.18 |
Book Value | $6.23 |
P/E Ratio | -139.8x |
Price/Sales (TTM) | 5.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -8.12% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
